{"id":208440,"date":"2026-08-18T09:30:24","date_gmt":"2026-08-18T04:00:24","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=208440"},"modified":"2026-08-18T09:30:25","modified_gmt":"2026-08-18T04:00:25","slug":"pramodini-medicare-initial-public-offering-allotment-status-18-august-2026","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/pramodini-medicare-initial-public-offering-allotment-status-18-august-2026\/","title":{"rendered":"Pramodini Medicare IPO Allotment Status 18 August 2026: What Investors Need to Track"},"content":{"rendered":"
<\/div>\n

Pramodini Medicare IPO: subscription closed 14 Aug 2026. Window 12-14 Aug. Allotment expected shortly. Healthcare and pharma SME IPO. Verify via registrar.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Pramodini Medicare IPO subscription closed on 14 August 2026 after a three-day window from 12 to 14 August. The company operates in the healthcare and pharmaceutical sector and the issue is now in the allotment phase. Investors who applied for investors can track their allotment status through the registrar’s website or BSE’s allotment portal. The listing date will be announced by the company within the SEBI-mandated timeline after allotment.<\/p>\n<\/div>\n

Pramodini Medicare IPO is drawing attention from retail and HNI investors on 18 August 2026 as the issue enters its subscription window. The Pramodini Medicare IPO covers the Healthcare and Pharmaceuticals sector, and the company is seeking to raise capital through a public listing on the SME segment of the stock exchange. Subscription has closed; allotment is expected shortly. Pramodini Medicare is engaged in the healthcare and pharmaceuticals sector, potentially covering medical devices, pharmaceutical products, or healthcare services. The company sought capital through its SME IPO to expand operations, strengthen its product portfolio, or fund general corporate purposes as detailed in its RHP.<\/p>\n

SME IPOs offer investors an opportunity to participate in the early-stage growth of smaller listed companies, but they also carry a distinct risk profile compared to mainboard IPOs. The this IPO is being closely watched by investors interested in the Healthcare and Pharmaceuticals space. Allotment date to be announced by the registrar. All subscription details including the price band, lot size, and issue size are available in the company’s SEBI-approved Red Herring Prospectus (RHP), which can be accessed through the NSE or BSE website and the registrar’s platform.<\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n